Tagcloud

ACE inhibitor, acetylcholinesterase inhibitor, aciclovir, acne, acute coronary syndrome, acute lymphoblastic leukaemia, ADHD, advanced prostate cancer, advanced renal cell carcinoma, advanced soft tissue sarcoma, adverse reaction, agomelatine, agoraphobia, alendronic acid, alfuzosin, algorithm, aliskiren, allergic rhinitis, allopurinol, alpha1-proteinase inhibitor, Alzheimer's, amantadine hydrochloride, ambrisentan, aminosalicylate, amlodipine, amoxicillin, anaemia, angina pectoris, anidulafungin, ankylosing spondylitis, anti-doping, anti-heparin, anti-human thymocyte immunoglobulin, antibacterial, antibiotic, anticoagulant, antidepressant, antineoplastic, antipsychotic, antiretroviral, antiretroviral therapy, anxiety, aromatase inhibitor, asthma, atazanavir, azacitidine, bacterial infections, BCG Vaccine, beclometasone, behaviour disorders, betamethasone, bevacizumab, bicalutamide, bipolar disorder, bisoprolol fumarate, bisphosphonates, black patients, bladder cancer, bowel cleansing, BPH, breakthrough pain, breast cancer, brinzolamide, bronchospasm, budesonide, bulimia nervosa, calcipotriol, calcium, candesartan, Candida albicans, candidiasis, carbetocin, carbidopa, cardiac insufficiency, cardiovascular disease, cefaclor, ceftriaxone, cefuroxime, cephalosporin, cetirizine, CHF, cholecalciferol, chronic constipation, chronic heart failure, Chronic Kidney Disease, chronic myeloid leukaemia, chronic myelomonocytic leukaemia, chronic pain, chronic pulmonary infection, ciprofloxacin, citalopram hydrobromide, clarithromycin, clavulanic acid, clopidogrel, clotrimazole, clozapine, colorectal cancer, contraception, COPD, coronary artery disease, Crohn’s Disease, cystic fibrosis, dabigatran etexilate, daptomycin, darunavir, dasatinib, degarelix, dementia, depression, dermatophytes, dermatophytose, desogestrel, diabetes, diclofenac, dienogest, diphteria, discontinuations, domperidone, donepezil, doxazosin, doxycycline, drospirenone, duodenal ulcer, dyslipidaemia, eczema, eletriptan, emetogenic cancer chemotherapy, enalapril, endocarditis, entacapone, epigastric bloating, epilepsy, epirubicin, epoetin, ErbB2 (HR2) receptors, erythropoiesis-stimulating agents, esomeprazole, estradiol, ethinylestradiol, etravirine, everolimus, exemestane, faecal impaction, famciclovir, fentanyl, fesoterodine, fever, filgrastim, finasteride, fluconazole, fluoxetine, flurbiprofen, fluvastatin, folate, folic acid, follicular development stimulation, follicular lymphoma, follitropin alpha, fosprepitant, fungal infections, gabapentin, gastric cancer, gastric ulcer, gastroduodenal ulcer, gemcitabine, gestodene, gliclazide, glucosamine sulphate, gonorrhoea, GORD, growth failure, H1N1, hayfever, heart failure, heart rate, Helicobacter pylori, hepatic failure, hepatitis, hepatocellular carcinoma, herpes, hip or knee replacement surgery, hip osteoarthritis, HIV, hyaluronic acid, hydrochlorothiazide, Hylan G-F 20, hypercholesterolaemia, hyperlipidaemia, hyperphosphataemia, hypertension, hyperuricaemia, hypoactive sexual desire disorder, ibritumomab, ibuprofen, IGF-1 deficiency, IMB, immunosuppression, indacaterol, indapamide, infections, inflammation, influenza, insomnia, interferon beta-1a, iobetasol, IOP, ipatropium bromide, irinotecan, Irish Sports Council, ischaemic stroke, isotretinoin, ivabradine, Kaposi's sarcoma, kidney cancer, kidney disease, knee osteoarthritis, lacosamide, lamotrigine, lansoprazole, lapatinib, laropiprant, lenalidomide, lercanidipine, leuprorelin acetate, levodopa, levonorgestrel, liraglutide, lisinopril, losartan, lutropin alpha, Lyme disease, macrogol, magnesium, mania, maraviroc, mecasermin, melatonergic, melatonin, meloxicam, memantine, mesalazine, metastatic colorectal carcinoma, metformin, methadone, methylnaltrexone bromide, methylphenidate hydrochloride, mexiletine hydrochloride, micafungin, migraine, mirtazapine, mixed dyslipidaemia, moxifloxacin, multiple myeloma, multiple sclerosis, muscular disorders, myelodysplastic syndromes, myocardial infarction, naloxone, naratriptan, nasal congestion, nausea, nebivolol, nephropathy, neural tube defects, neutropenia, NICE guidelines, nicotine, nicotinic acid, nilotinib, NSCLC, nutrition, OCD, ocular hypertension, olanzapine, olmesartan, omeprazole, ondensetron, open angle glaucoma, opioid addiction, opioid analgesic, opioid-induced constipation, oseltamivir, osteoarthritis, osteonecrosis of the jaw, osteoporosis, otitis, ovarian cancer, overactive bladder syndrome, oxycodone, paclitaxel, pain, pancreatic cancer, pancreatic exocrine insufficiency, pancreatin, panic disorder, panitumumab, pantoprazole, paracetamol, Parkinson’s, partial-onset seizures, patch, pemetrexed, peptic ulcer, perindopril, peripheral arterial disease, peripheral neuropathic pain, pertussis, piperacillin, Pityriasis versicolor, poliomyelitis, post transplantation hyperlipidaemia, post-operative pain, post-traumatic stress disorder, PPIs, pramipexole, pravastatin, pregnancy, pricing policy, primary hypercholesterolaemia, probiotics, prostate cancer, protamine sulphate, Pseudomonas aeruginosa, psoriasis, psychotic disorders, pulmonary arterial hypertension, pulmonary embolism, quetiapine, raltegravir, ramipril, ranolazine, rasagiline, recombinant IGF-1, reflux oesophagitis, renal disease, renin inhibitor, Restless Legs Syndrome, rheumatoid arthritis, ribavirin, ringworm, risedronate sodium, risperidone, rivaroxaban, rivastigmine, romiplostim, ropinirole, rosacea, RTI, S. aureus, salbutamol, sarcoma, saxagliptin, schizophrenia, SCLC, sertraline, sevelamer carbonate, severe pain, simvastatin, sitagliptin, smoking cessation, sodium alginate, solide organ transplantation, sorafenib, sore throat, spasticity, spinal cord injury, sport, sprain, statins, stroke, strontium ranelate, suicide, systemic embolisation, telmisartan, temsirolimus, terbinafine, testosterone, tetanus, thalidomide, thrombocytopenic purpura, thrush, tibolone, timolol, tinea, tiotropium, tipranavir, tizanidine, tobramycin, tocilizumab, topotecan, trabectedin, tramadol, Trichophyton, trimethoprim, trospium chloride, ustekinumab, UTI, vaccine, valaciclovir, valproate, valsartan, varenicline, venlafaxine, venous thromboembolism, venous thrombosis, vildagliptin, vinorelbine, vitamin D, vomiting, WADA, warfarin, wound, zanamivir, zoledronic acid, Zollinger-Ellison syndrome

MIMS Ireland: February 2010

Reduced duration of common winter infections in the elderly with Actimel

01 February 2010 | New Clinical Evidence

Probiotics or have long been the focus of considerable research to demonstrate their potential health benefits including: preventing C. difficile infection, antibiotic-associated diarrhoea and infant eczema.... Read more

Micardis approved to reduce cardiovascular risk

01 February 2010 | New Clinical Evidence

Boehringer Ingelheim wish to announce that the European Commission has approved Micardis (telmisartan) for the reduction of cardiovascular morbidity in patients with: I. manifest atherothrombotic cardiovascular disease (history of coronary heart disease, stroke, or peripheral arterial disease) or, II. type... Read more

Mirapexin prolonged-release, new once daily tablet for PD

01 February 2010 | New Clinical Evidence

Boehringer Ingelheim wish to announce that new Mirapexin (pramipexole) prolonged-release, once daily tablet has been granted marketing authorisation by the European Commission in all EU/EEA countries for the treatment of early and advanced idiopathic Parkinson’s disease (PD).... Read more

Avoiding Medication Errors with Perindopril Arginine/ Amlodipine (Acerycal) Combination Products

01 February 2010 | Irish Medicines Board

The Irish Medicines Board has recently authorised the following combination products containing perindopril arginine and amlodipine (Acerycal) for the Irish market.... Read more

Citalopram Teva

01 February 2010 | New Products

Company: Teva Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Citalopram hydrobromide eq. to citalopram 40mg. Description: White oval film-coated tablet with a break-line on one side. Presentation: 40mg-28, €27.10. Indication: Major depressive episodes.... Read more

Clopidogrel TAD

01 February 2010 | New Products

Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Clopidogrel (HCl) 75mg. Description: Pink, round and slightly convex film-coated tablets. Presentation: 28, €33.58. Indications: Prevention of atherothrombotic events in adult patients suffering from myocardial infarction (from a... Read more

Onglyza

01 February 2010 | New Products

Company: Bristol-Myers Squibb Pharmaceuticals / AstraZeneca Pharmaceuticals (Ireland) Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Saxagliptin (HCl) 5mg. Description: Pink, biconvex, round, film-coated tablet, with 5 printed on one side and 4215 on the other side. Presentation: 28,... Read more

Synvisc & Synvisc-One

01 February 2010 | New Products

Company: Genzyme Therapeutics. Legal category: Medical device. Active ingredient: Hylan G-F 20, 2ml (Synvisc), 6ml (Synvisc-One). Description: Synvisc: 2.25ml glass syringe containing 2ml hylan G-F 20. Synvisc-One: 10ml glass syringe containing 6ml hylan G-F 20. Presentation: Synvisc: 1, €88; 3,... Read more

Aptivus Oral Solution

01 February 2010 | New Presentations

Company: Boehringer Ingelheim Ireland Ltd. Legal category: Prescription. Hospital. Sport permitted. Active ingredient: Tipranavir 100mg/ml. Description: Clear yellow viscous liquid. Presentation: €229.59. Indications: Co-administered with low dose ritonavir, HIV-1 infection in highly pre-treated children from 2-12 years with virus resistant... Read more

Mirapexin Prolonged-release

01 February 2010 | New Presentations

Company: Boehringer Ingelheim Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Pramipexole (as dihydrochloride monohydrate) 0.26mg, 0.52mg, 1.05mg, 2.1mg, 3.15mg. Description: White to off white tablets embossed with Boehringer Ingelheim company symbol on one side and either P1,... Read more

Clonfolic 0.4mg 28 Pack OTC Only

01 February 2010 | New this Month

Clonmel Healthcare wish to inform you that from 1st February 2010 Clonfolic 0.4mg 28 pack will no longer be available as a GMS reimbursable Product. Clonfolic 0.4mg 28 pack will still be available as an OTC product only. Please rest... Read more

Micardis Now Indicated for Cardiovascular Prevention in High Risk Patients

01 February 2010 | New this Month

Micardis (telmisartan) is now approved by the European Commission for the reduction of cardiovascular (CV) morbidity in patients with manifest atherothrombotic CV disease or type 2 diabetes with documented target organ damage. This new indication is based on a review... Read more